Diagnostics & Research
The Diagnostics & Research industry has a total of 46 stocks, with a combined market cap of $787.43 billion, total revenue of $171.6 billion and a weighted average PE ratio of 43.29.
Market Cap
787.43B
Revenue
171.6B
Profits
18.19B
PE Ratio
43.29
Profit Margin
10.60%
Dividend Yield
0.21%
46 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 212.48B | 0.06% | 550,176 | 46.34B |
| 2 | DHR | Danaher Corporation | 138.12B | 0.77% | 843,768 | 25.11B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 44.71B | 1.39% | 267,770 | 4.45B |
| 4 | A | Agilent Technologies, Inc. | 39.27B | 0.48% | 392,390 | 7.23B |
| 5 | NTRA | Natera, Inc. | 38.51B | 0.41% | 328,705 | 2.50B |
| 6 | IQV | IQVIA Holdings Inc. | 38.17B | -1.34% | 565,447 | 16.98B |
| 7 | WAT | Waters Corporation | 36.97B | -0.20% | 247,493 | 3.77B |
| 8 | ILMN | Illumina, Inc. | 30.71B | -0.83% | 558,565 | 4.49B |
| 9 | MTD | Mettler-Toledo International Inc. | 28.73B | 1.25% | 48,928 | 4.13B |
| 10 | DGX | Quest Diagnostics Incorporated | 25.66B | -0.24% | 229,378 | 11.56B |
| 11 | LH | Labcorp Holdings Inc. | 24.98B | -0.16% | 135,298 | 14.35B |
| 12 | GH | Guardant Health, Inc. | 21.81B | 0.33% | 637,818 | 1.18B |
| 13 | MEDP | Medpace Holdings, Inc. | 16.07B | -0.27% | 51,954 | 2.78B |
| 14 | RVTY | Revvity, Inc. | 12.87B | 2.52% | 543,954 | 2.90B |
| 15 | ICLR | ICON Public Limited Company | 12.22B | -3.14% | 267,023 | 8.29B |
| 16 | CRL | Charles River Laboratories International, Inc. | 11.05B | -1.37% | 171,394 | 4.03B |
| 17 | QGEN | Qiagen N.V. | 8.72B | 1.84% | 705,905 | 2.10B |
| 18 | BLLN | BillionToOne, Inc. | 6.33B | -0.76% | 263,735 | 354.54M |
| 19 | TWST | Twist Bioscience Corporation | 6.13B | 7.53% | 1,194,032 | 431.80M |
| 20 | RDNT | RadNet, Inc. | 5.20B | 3.65% | 122,280 | 2.14B |
| 21 | SHC | Sotera Health Company | 5.15B | 1.18% | 254,651 | 1.19B |
| 22 | ADPT | Adaptive Biotechnologies Corporation | 3.72B | 3.59% | 799,964 | 308.08M |
| 23 | VCYT | Veracyte, Inc. | 3.67B | -1.34% | 482,418 | 561.90M |
| 24 | GRAL | GRAIL, Inc. | 3.06B | 3.89% | 95,697 | 156.12M |
| 25 | CDNA | CareDx, Inc. | 2.48B | 9.86% | 1,002,760 | 458.09M |
| 26 | NEO | NeoGenomics, Inc. | 2.06B | 4.64% | 457,852 | 766.30M |
| 27 | WGS | GeneDx Holdings Corp. | 1.99B | 2.92% | 312,731 | 442.68M |
| 28 | PSNL | Personalis, Inc. | 1.39B | 4.58% | 1,001,421 | 64.52M |
| 29 | FRNM | Freenome, Inc. | 1.28B | 1.79% | 208,878 | 34.24M |
| 30 | OPK | OPKO Health, Inc. | 1.02B | 3.03% | 1,219,854 | 587.90M |
| 31 | CSTL | Castle Biosciences, Inc. | 901.52M | 5.39% | 177,123 | 357.28M |
| 32 | FLGT | Fulgent Genetics, Inc. | 481.52M | 5.74% | 102,016 | 323.93M |
| 33 | MYGN | Myriad Genetics, Inc. | 293.17M | 7.17% | 2,098,264 | 806.60M |
| 34 | BDSX | Biodesix, Inc. | 230.00M | 4.76% | 11,815 | 96.10M |
| 35 | IMDX | Insight Molecular Diagnostics Inc. | 161.45M | 7.53% | 57,747 | 1.95M |
| 36 | XGN | Exagen Inc. | 112.58M | 2.87% | 46,394 | 68.38M |
| 37 | BNR | Burning Rock Biotech Limited | 93.86M | - | 38 | 74.58M |
| 38 | PRPO | Precipio, Inc. | 40.13M | 3.70% | 58,864 | 25.83M |
| 39 | QUCY | Quantum Cyber N.V. | 27.32M | 5.26% | 201,040 | 537.08K |
| 40 | MDXH | MDxHealth SA | 22.88M | 6.56% | 85,551 | 110.97M |
| 41 | ADVB | Advanced Biomed Inc. | 13.08M | -1.00% | 23,397 | - |
| 42 | XWEL | XWELL, Inc. | 8.95M | 8.16% | 13,613 | 28.83M |
| 43 | MBAI | Check-Cap Ltd. | 8.16M | -0.47% | 2,235 | - |
| 44 | NDRA | ENDRA Life Sciences Inc. | 6.00M | 0.53% | 2,361 | - |
| 45 | ISPC | iSpecimen Inc. | 2.87M | 5.82% | 10,668 | 1.03M |
| 46 | BIAF | bioAffinity Technologies, Inc. | 2.73M | -3.87% | 98,726 | 5.66M |